News
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in investor meetings at ...
The Washington Mystics have a new jersey sponsor for the 2025 season. It's a local company that's made a big sports marketing ...
Analysts have given Lexicon Pharmaceuticals a total of 5 ratings, with the consensus rating being Buy. The average one-year ...
Despite a 5% revenue increase, Vanda Pharmaceuticals Inc (VNDA) faces challenges with a significant net loss and rising operating expenses. WASHINGTON (AP) — Vanda Pharmaceuticals Inc. VNDA ...
The following analysis focuses on the analyst ratings and average 1-year price targets of Abeona Therapeutics, 2seventy bio and Vanda Pharmaceuticals, three prominent industry players, providing ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The U.S. Food and Drug Administration (FDA) has cleared the first blood test to aid in diagnosis of Alzheimer's disease. The test detects amyloid plaques, a hallmark of Alzheimer's disease, through a ...
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer ...
UK group Cycle Pharma has made an unsolicited takeover bid to buy Vanda Pharma of the US, which is already fending off an overture from Future Pak. The $8-per-share offer values Nasdaq-listed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results